申请人:Aventis Pharmaceuticals Inc.
公开号:US08053458B2
公开(公告)日:2011-11-08
The present invention is directed to dipyrazole compounds of formula I and their pharmaceutically acceptable salts, stereoisomers, tautomers, or solvates thereof. Novel compounds include those of formula I.
The compounds of this invention modulate AMPA and NMDA receptor function, and therefore are useful as pharmaceutical agents, especially for the treatment of neuropsychiatric disorders.
本发明涉及式I的二吡唑化合物及其药学上可接受的盐、立体异构体、互变异构体或其溶剂化物。新颖的化合物包括式I的化合物。本发明的化合物调节AMPA和NMDA受体功能,因此可用作药物制剂,特别是用于治疗神经精神障碍。